Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, Morgan JM, Capuzzi DM
Published in The American Journal of Cardiology
Key Findings
Over 4.5 years Xuezhikang reduced recurrent coronary events by about 45 percent and total mortality by about 33 percent versus placebo after myocardial infarction.
Conclusions
A red yeast rice extract reduced hard cardiovascular outcomes in secondary prevention.
Limitations
Single-country trial; product differs from Western supplements; open questions on generalisability.
Supplements Studied
Over 4.5 years Xuezhikang reduced recurrent coronary events by about 45 percent and total mortality by about 33 percent.
Outcomes Measured
Xuezhikang reduced recurrent coronary events and total mortality after myocardial infarction.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.